120 related articles for article (PubMed ID: 10419777)
1. Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis.
Amin AR
Osteoarthritis Cartilage; 1999 Jul; 7(4):392-4. PubMed ID: 10419777
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha.
Patel IR; Attur MG; Patel RN; Stuchin SA; Abagyan RA; Abramson SB; Amin AR
J Immunol; 1998 May; 160(9):4570-9. PubMed ID: 9574564
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis.
Zhao J; Chen H; Peschon JJ; Shi W; Zhang Y; Frank SJ; Warburton D
Dev Biol; 2001 Apr; 232(1):204-18. PubMed ID: 11254358
[TBL] [Abstract][Full Text] [Related]
5. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25.
Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N
Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800
[TBL] [Abstract][Full Text] [Related]
7. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.
Althoff K; Reddy P; Voltz N; Rose-John S; Müllberg J
Eur J Biochem; 2000 May; 267(9):2624-31. PubMed ID: 10785383
[TBL] [Abstract][Full Text] [Related]
8. Biology of TACE inhibition.
Newton RC; Solomon KA; Covington MB; Decicco CP; Haley PJ; Friedman SM; Vaddi K
Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii25-32. PubMed ID: 11890648
[TBL] [Abstract][Full Text] [Related]
9. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis.
Shlopov BV; Gumanovskaya ML; Hasty KA
Arthritis Rheum; 2000 Jan; 43(1):195-205. PubMed ID: 10643716
[TBL] [Abstract][Full Text] [Related]
10. In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue.
Ermert M; Pantazis C; Duncker HR; Grimminger F; Seeger W; Ermert L
Cytokine; 2003 May; 22(3-4):89-100. PubMed ID: 12849708
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis.
Satoh M; Nakamura M; Satoh H; Saitoh H; Segawa I; Hiramori K
J Am Coll Cardiol; 2000 Oct; 36(4):1288-94. PubMed ID: 11028485
[TBL] [Abstract][Full Text] [Related]
12. Activation of diverse eicosanoid pathways in osteoarthritic cartilage: a lipidomic and genomic analysis.
Attur M; Dave M; Abramson SB; Amin A
Bull NYU Hosp Jt Dis; 2012; 70(2):99-108. PubMed ID: 22891999
[TBL] [Abstract][Full Text] [Related]
13. Release of tumour necrosis factor alpha (TNFalpha) by TNFalpha cleaving enzyme (TACE) in response to septic stimuli in vitro.
Robertshaw HJ; Brennan FM
Br J Anaesth; 2005 Feb; 94(2):222-8. PubMed ID: 15556967
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tenascin-C expression by tumor necrosis factor-alpha in cultured human osteoarthritis chondrocytes.
Nakoshi Y; Hasegawa M; Sudo A; Yoshida T; Uchida A
J Rheumatol; 2008 Jan; 35(1):147-52. PubMed ID: 18061975
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of tumour necrosis factor-alpha and its converting enzyme in human abdominal aortic aneurysm.
Satoh H; Nakamura M; Satoh M; Nakajima T; Izumoto H; Maesawa C; Kawazoe K; Masuda T; Hiramori K
Clin Sci (Lond); 2004 Mar; 106(3):301-6. PubMed ID: 14580234
[TBL] [Abstract][Full Text] [Related]
17. The role of C-C chemokines and their receptors in osteoarthritis.
Yuan GH; Masuko-Hongo K; Sakata M; Tsuruha J; Onuma H; Nakamura H; Aoki H; Kato T; Nishioka K
Arthritis Rheum; 2001 May; 44(5):1056-70. PubMed ID: 11352237
[TBL] [Abstract][Full Text] [Related]
18. Stroke-induced subventricular zone proliferation is promoted by tumor necrosis factor-alpha-converting enzyme protease activity.
Katakowski M; Chen J; Zhang ZG; Santra M; Wang Y; Chopp M
J Cereb Blood Flow Metab; 2007 Apr; 27(4):669-78. PubMed ID: 16926839
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis.
Westacott CI; Barakat AF; Wood L; Perry MJ; Neison P; Bisbinas I; Armstrong L; Millar AB; Elson CJ
Osteoarthritis Cartilage; 2000 May; 8(3):213-21. PubMed ID: 10806049
[TBL] [Abstract][Full Text] [Related]
20. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis.
Chan BY; Fuller ES; Russell AK; Smith SM; Smith MM; Jackson MT; Cake MA; Read RA; Bateman JF; Sambrook PN; Little CB
Osteoarthritis Cartilage; 2011 Jul; 19(7):874-85. PubMed ID: 21619935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
